Allergan expected to post EPS of $4.73 for 2017 — 3 insights

Stock market analysts anticipate Allergan will report full-year earnings of $4.73 per share Feb. 14, according to the Frisco Fastball.


Here's what you should know:

1. Analysts believe Allergan will announce fourth quarter 2017 earnings of $0.83 per share Feb. 14, as well.

2. Analysts believe the company's full-year earnings will increase approximately 13.98 percent, year over year.

3. Based on the projected earnings, 18 analysts awarded Allergan a "buy" rating and eight have deemed it a "hold." No analysts issued a "sell" rating.

More articles on supply chain:
Healthcare-related lobbying hits $555M in 2017 — 6 statistics on lobbying in healthcare
Advanced Medical Group joins National Spine & Pain Centers — 4 things to know
Preoperative opioid users more likely to abuse opioids after TKA — 3 study insights

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months